• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enzymatic and immunologic identification of succinic semialdehyde dehydrogenase in rat and human neural and nonneural tissues.

作者信息

Chambliss K L, Zhang Y A, Rossier E, Vollmer B, Gibson K M

机构信息

Metabolic Disease Center, Baylor Research Institute, Dallas, TX 75226, USA.

出版信息

J Neurochem. 1995 Aug;65(2):851-5. doi: 10.1046/j.1471-4159.1995.65020851.x.

DOI:10.1046/j.1471-4159.1995.65020851.x
PMID:7616245
Abstract

We have identified succinic semialdehyde dehydrogenase protein in rat and human neural and nonneural tissues. Tissue localization was determined by enzymatic assay and by western immunoblotting using polyclonal antibodies raised in rabbit against the purified rat brain protein. Although brain shows the highest level of succinic semialdehyde dehydrogenase activity, substantial amounts of enzyme activity occur in mammalian liver, pituitary, heart, and ovary. We further demonstrate the absence of succinic semialdehyde dehydrogenase enzyme activity and protein in brain, liver, and kidney tissue samples from an individual affected with succinic semialdehyde dehydrogenase deficiency, thereby verifying the specificity of our antibodies.

摘要

相似文献

1
Enzymatic and immunologic identification of succinic semialdehyde dehydrogenase in rat and human neural and nonneural tissues.
J Neurochem. 1995 Aug;65(2):851-5. doi: 10.1046/j.1471-4159.1995.65020851.x.
2
Enzymatic and immunological demonstration of normal and defective succinic semialdehyde dehydrogenase activity in fetal brain, liver and kidney.胎儿脑、肝和肾中正常和缺陷型琥珀酸半醛脱氢酶活性的酶学和免疫学证明
J Inherit Metab Dis. 1993;16(3):523-6. doi: 10.1007/BF00711671.
3
Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum.
Int J Biochem. 1992 Sep;24(9):1493-9. doi: 10.1016/0020-711x(92)90077-e.
4
Studies on analogues of succinic semialdehyde as substrates for succinate semialdehyde dehydrogenase from rat brain.
J Neurochem. 1986 Jun;46(6):1895-8. doi: 10.1111/j.1471-4159.1986.tb08510.x.
5
Human brain glyceraldehyde-3-phosphate dehydrogenase, succinic semialdehyde dehydrogenase and aldehyde dehydrogenase isozymes: substrate specificity and sensitivity to disulfiram.人脑海藻糖-3-磷酸脱氢酶、琥珀酸半醛脱氢酶和醛脱氢酶同工酶:底物特异性及对双硫仑的敏感性
Alcohol Clin Exp Res. 1989 Dec;13(6):755-61. doi: 10.1111/j.1530-0277.1989.tb00416.x.
6
Kinetic studies with rat-brain succinic-semialdehyde dehydrogenase.大鼠脑琥珀酸半醛脱氢酶的动力学研究
Eur J Biochem. 1981 Jun;117(1):187-93. doi: 10.1111/j.1432-1033.1981.tb06319.x.
7
Human brain "high Km" aldehyde dehydrogenase: purification, characterization, and identification as NAD+ -dependent succinic semialdehyde dehydrogenase.人脑中的“高Km值”醛脱氢酶:纯化、特性鉴定及作为NAD⁺依赖性琥珀酰半醛脱氢酶的鉴定
Arch Biochem Biophys. 1988 Nov 1;266(2):386-96. doi: 10.1016/0003-9861(88)90270-6.
8
Methodological problems in the histochemical demonstration of succinate semialdehyde dehydrogenase activity.琥珀酸半醛脱氢酶活性组织化学显示中的方法学问题
Histochem J. 1983 Dec;15(12):1161-76. doi: 10.1007/BF01002737.
9
Succinic semialdehyde dehydrogenase activity in bovine adrenal medulla and blood platelets: a comparative study with the brain enzyme.牛肾上腺髓质和血小板中琥珀酸半醛脱氢酶活性:与脑酶的比较研究
Comp Biochem Physiol B. 1987;86(3):489-92. doi: 10.1016/0305-0491(87)90436-6.
10
Brain succinic semialdehyde dehydrogenase: identification of reactive lysyl residues labeled with pyridoxal-5'-phosphate.脑琥珀酸半醛脱氢酶:用磷酸吡哆醛标记的反应性赖氨酸残基的鉴定。
J Neurochem. 2001 Feb;76(3):919-25. doi: 10.1046/j.1471-4159.2001.00147.x.

引用本文的文献

1
Succinic Semialdehyde Dehydrogenase Deficiency: An Update.琥珀酸半醛脱氢酶缺乏症:更新。
Cells. 2020 Feb 19;9(2):477. doi: 10.3390/cells9020477.
2
Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.NCS-382,一种 γ-羟基丁酸(GHB)受体配体的毒理学/转运特性:对 SSADH 缺乏症(一种 GABA 代谢紊乱)的治疗意义。
Toxicol In Vitro. 2018 Feb;46:203-212. doi: 10.1016/j.tiv.2017.10.015. Epub 2017 Oct 12.
3
Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
ALDH5A1表达降低可预测卵巢癌患者的预后。
Cancer Biol Ther. 2017 Apr 3;18(4):245-251. doi: 10.1080/15384047.2017.1295175. Epub 2017 Mar 27.
4
Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.琥珀酸半醛脱氢酶缺乏症(SSADHD):γ-氨基丁酸代谢罕见单基因疾病中的病理生理复杂性和多因素性状关联
Neurochem Int. 2016 Oct;99:72-84. doi: 10.1016/j.neuint.2016.06.009. Epub 2016 Jun 14.
5
Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.γ-氨基丁酸(GABA)代谢紊乱:琥珀酸半醛脱氢酶(SSADH)和GABA转氨酶缺乏症。
J Pediatr Epilepsy. 2014 Nov 25;3(4):217-227. doi: 10.3233/PEP-14097.
6
Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.琥珀酸半醛脱氢酶缺乏症,一种 GABA 代谢紊乱:发现 30 年后的临床试验。
J Inherit Metab Dis. 2013 May;36(3):401-10. doi: 10.1007/s10545-012-9499-5. Epub 2012 Jun 28.
7
Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.琥珀酸半醛脱氢酶:生化-分子-临床疾病机制、氧化还原调控及功能意义。
Antioxid Redox Signal. 2011 Aug 1;15(3):691-718. doi: 10.1089/ars.2010.3470. Epub 2011 Apr 10.
8
Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.乙醛脱氢酶5a1(琥珀酸半醛脱氢酶)的比较基因组学及其缺乏相关的γ-羟基丁酸积累。
Hum Genomics. 2009 Jan;3(2):106-20. doi: 10.1186/1479-7364-3-2-106.
9
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.琥珀酸半醛脱氢酶(SSADH;ALDH5a1)缺乏症(γ-羟基丁酸尿症)的治疗理念。基于25年的患者评估、对Aldh5a1基因敲除小鼠的研究以及γ-羟基丁酸药理学特性所形成的假说。
J Inherit Metab Dis. 2007 Jun;30(3):279-94. doi: 10.1007/s10545-007-0574-2. Epub 2007 Apr 24.
10
Unusual enzyme findings in five patients with metabolic profiles suggestive of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).五名代谢谱提示琥珀酸半醛脱氢酶缺乏症(4-羟基丁酸尿症)患者的异常酶学发现。
J Inherit Metab Dis. 1998 Jun;21(3):255-61. doi: 10.1023/a:1005368106563.